Liang Deng

USPTO Granted Patents = 16 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 49(Granted Patents)

Company Filing History:

16 out of 559

Memorial Sloan Kettering Cancer Center

patents

1 out of 712

The Rockefeller University

patents

1 out of 1,454

Rutgers, the State University of New Jersey

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12397029 - Use of MVA or MVADELTAE3L as immunotherapeutic agents against solid tumors (2025-08-26),

2. 12252702 - Recombinant poxviruses for cancer immunotherapy (2025-03-18),

3. 12036279 - Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors (2024-07-16),

4. 11986503 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy (2024-05-21),

5. 11884939 - Vaccinia virus mutants useful for cancer immunotherapy (2024-01-30),

6. 11541087 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy (2023-01-03),

7. 11426460 - Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors (2022-08-30),

8. 11285209 - Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors (2022-03-29),

9. 11253560 - Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors (2022-02-22),

10. 11242509 - Vaccinia virus mutants useful for cancer immunotherapy (2022-02-08),

11. 10765711 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy (2020-09-08),

12. 10736962 - Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors (2020-08-11),

13. 10639366 - Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors (2020-05-05),

14. 10548930 - Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors (2020-02-04),

15. 10512662 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy (2019-12-24),

Title: The Innovative Journey of Inventor Liang Deng

Introduction: Liang Deng, a pioneering inventor based in New York, NY, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Liang Deng's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Liang Deng has established himself as a leading figure in the innovation landscape. His work has not only revolutionized existing industries but has also paved the way for new technological advancements.

Collaborations: Throughout his career, Liang Deng has collaborated with top research institutions, leading companies, and innovative startups to bring his ideas to life. His ability to work across disciplines and industries has led to the development of groundbreaking solutions with real-world applications.

Conclusion: Liang Deng's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, continues to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is undeniable, and his legacy will undoubtedly shape the future of innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

4 patents pending:

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

8 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.